Plant and Drug Research Studies
World’s largest research centre to look into surprising health benefits of psychedelic drugs The Telegraph
The world’s largest pyschedelics research centre has been launched to examine whether the drugs can treat conditions such as depression and opioid addiction …
Johns Hopkins Medicine Opens Center for Psychedelic Research Interesting Engineering
Psychedelic-assisted therapy is nothing new. However, there has been rekindled interest in the mysterious world of psychedelics as research has revealed that …
Researchers found that men who ate mushrooms more than three times a week had a 17% lower risk of prostate cancer — but these men were probably …
Johns Hopkins to Expand Psychedelics-As-Medicine Research With $17 Million Center https://karmaimpact.com
Magic mushrooms as treatment for depression, PTSD other issues is getting a major boost at Johns Hopkins University, as researchers continue efforts, …
New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer’s, addiction and more FierceBiotech
Although psychedelic drugs have shown promise in the treatment of multiple diseases, research into these compounds has been stymied. Johns Hopkins is …
Berkeley City Council To Vote On Decriminalizing Psychedelics Marijuana Moment
The Berkeley, California City Council will decide next week whether to advance a resolution to decriminalize psychedelics like psilocybin mushrooms and …
Panel discussion promises to be surreal, sublime and psychedelic The Mercury News
Art lovers looking to expand their understanding of the surreal and sublime now have the chance to dive into the world of psychedelics at the San Jose Institute …
Microdosing, Depression, and the Trippy Future of Mental Health Treatments Glamour
Microdosing for depression is on the rise. Psychedelics are a fringe frontier of mental health treatments. But are they safe?
A battered Zafgen seeks strategic options, prophesying ongoing study will unlikely lift FDA hold on diabetes drug Endpoints News
The ‘mind-blowing’ R&D renaissance in psychedelic meds finds a home at Johns Hopkins. The “mind-blowing” field of psychedelic research is getting its first …